
Sign up to save your podcasts
Or


Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner.
18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation. Ulaner et al. Radiology 2022; 305:419–428.
By The Radiological Society of North America4.7
8787 ratings
Dr. Manisha Bahl discusses the role of DCFPyL PET/CT in patients with initially diagnosed and biochemically recurrent prostate cancer with Dr. Gary Ulaner.
18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation. Ulaner et al. Radiology 2022; 305:419–428.

4,354 Listeners

497 Listeners

28 Listeners

76 Listeners

2,442 Listeners

29 Listeners

8,747 Listeners

459 Listeners

608 Listeners

45 Listeners

202 Listeners

9,807 Listeners

1,622 Listeners

57 Listeners

41 Listeners